Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill M Weimer

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Scientific Reports|March 21, 2020
Longitudinal phenotype development in a minipig model of neurofibromatosis type 1Johanna Uthoff, Jared Larson, Takashi S Sato, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Sortilin inhibition treats multiple neurodegenerative lysosomal storage disordersHannah G Leppert, Joelle T Anderson, Kaylie J Timm, et al.
The Journal of Biological Chemistry|May 10, 2021
Endolysosomal N-glycan processing is critical to attain the most active form of the enzyme acid alpha-glucosidaseNithya Selvan, Nickita Mehta, Suresh Venkateswaran, et al.
Progress in Neurobiology|March 22, 2020
A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative diseaseTyler B Johnson, Jon J Brudvig, Kimmo K Lehtimäki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2020
AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten DiseaseTyler B Johnson, Katherine A White, Jon J Brudvig, et al.
Clinical and Translational Science|June 27, 2024
NF1<sup>+/ex42del</sup> miniswine model the cellular disruptions and behavioral presentations of NF1-associated cognitive and motor impairmentVicki J Swier, Katherine A White, Pedro L Negrão de Assis, et al.
The Journal of Clinical Investigation|December 15, 2025
Corrigendum to A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transferLakshya Bajaj, Jaiprakash Sharma, Alberto di Ronza, et al.
Molecular Therapy. Methods & Clinical Development|March 5, 2021
Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease miceKatherine A White, Hemanth R Nelvagal, Timothy A Poole, et al.
The Journal of Clinical Investigation|June 30, 2020
A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transferLakshya Bajaj, Jaiprakash Sharma, Alberto di Ronza, et al.
Frontiers in Genetics|April 10, 2023
Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 diseaseTyler B Johnson, Jon J Brudvig, Shibi Likhite, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Scientific Reports|March 21, 2020
Longitudinal phenotype development in a minipig model of neurofibromatosis type 1Johanna Uthoff, Jared Larson, Takashi S Sato, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Sortilin inhibition treats multiple neurodegenerative lysosomal storage disordersHannah G Leppert, Joelle T Anderson, Kaylie J Timm, et al.
The Journal of Biological Chemistry|May 10, 2021
Endolysosomal N-glycan processing is critical to attain the most active form of the enzyme acid alpha-glucosidaseNithya Selvan, Nickita Mehta, Suresh Venkateswaran, et al.
Progress in Neurobiology|March 22, 2020
A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative diseaseTyler B Johnson, Jon J Brudvig, Kimmo K Lehtimäki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2020
AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten DiseaseTyler B Johnson, Katherine A White, Jon J Brudvig, et al.
Clinical and Translational Science|June 27, 2024
NF1<sup>+/ex42del</sup> miniswine model the cellular disruptions and behavioral presentations of NF1-associated cognitive and motor impairmentVicki J Swier, Katherine A White, Pedro L Negrão de Assis, et al.
The Journal of Clinical Investigation|December 15, 2025
Corrigendum to A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transferLakshya Bajaj, Jaiprakash Sharma, Alberto di Ronza, et al.
Molecular Therapy. Methods & Clinical Development|March 5, 2021
Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease miceKatherine A White, Hemanth R Nelvagal, Timothy A Poole, et al.
The Journal of Clinical Investigation|June 30, 2020
A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transferLakshya Bajaj, Jaiprakash Sharma, Alberto di Ronza, et al.
Frontiers in Genetics|April 10, 2023
Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 diseaseTyler B Johnson, Jon J Brudvig, Shibi Likhite, et al.
Pageof 9